← All organizations

Institut de Cancerologie Strasbourg Europe

Academic/Hospital

Also known as: Institut de Cancerologie Strasbourg Europe | Institut de cancérologie Strasbourg Europe

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 1, 2025

Timeline

No events for the selected filters.

Drugs by trial phase (10 distinct, 8 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (5 own, 0 via acquisition)

Indications

Studied for

Recent trials (13)

NCT06476704OfficialPhase 2Jan 1, 2025
NCT06476704Lead sponsorPhase 2Jan 1, 2025
NCT06477939OfficialPhase 3Jan 1, 2025
NCT06477939Lead sponsorPhase 3Jan 1, 2025
NCT06725368OfficialPhase 2Dec 1, 2024
NCT06725368Lead sponsorPhase 2Dec 1, 2024
NCT05698186Study chairPhase 3May 15, 2023
NCT05698186Lead sponsorPhase 3May 15, 2023
NCT05512403Overall official - principal investigatorPhase 3Jan 30, 2023
NCT05388500Lead sponsorPhase 3Dec 15, 2022
NCT05388500Study chairPhase 3Dec 15, 2022
NCT04392128Lead sponsorPhase 2May 12, 2020
NCT04378920Lead sponsorPhase 1/Phase 2Apr 14, 2020

Details

Last known activity: Jan 1, 2025